Intravenous levosimendan-norepinephrine combination during off-pump coronary artery bypass grafting in a hemodialysis patient with severe myocardial dysfunction

 
This item is provided by the institution :

Repository :
Nemertes
see the original item page
in the repository's web site and access all digital files if the item*
share




2010 (EN)

Intravenous levosimendan-norepinephrine combination during off-pump coronary artery bypass grafting in a hemodialysis patient with severe myocardial dysfunction

Papadopoulos, Georgios
Karanikolas, Menelaos
Baikoussis, Nikolaos G
Siminelakis, Stavros N
Tzimas, Petros

Παπαδόπουλος, Γεώργιος
Μπαϊκούσσης, Νικόλαος
Τζίμας, Πέτρος
Συμινελάκης, Σταύρος
Καρανικόλας, Μενέλαος

This the case of a 63 year-old man with end-stage renal disease (on chronic hemodialysis), unstable angina and significantly impaired myocardial contractility with low left ventricular ejection fraction, who underwent off-pump one vessel coronary bypass surgery. Combined continuous levosimendan and norepinephrine infusion (at 0.07 μg/kg/min and 0.05 μg/kg/min respectively) started immediately after anesthesia induction and continued for 24 hours. The levosimendan/norepinephrine combination helped maintain an appropriate hemodynamic profile, thereby contributing to uneventful completion of surgery and postoperative hemodynamic stability. Although levosimendan is considered contraindicated in ESRD patients, this case report suggests that combined perioperative levosimendan/norepinephrine administration can be useful in carefully selected hemodialysis patients with impaired myocardial contractility and ongoing myocardial ischemia, who undergo off-pump myocardial revascularization surgery.

Journal (paper)

hemodialysis
myocardial dysfunction


Journal of Cardiothoracic Surgery

English

2012-01-10T07:36:06Z
2010-03-02
2012-01-10


Journal of Cardiothoracic Surgery




*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)